Impact of pembrolizumab (pembro) versus paclitaxel on health-related quality of life (HRQoL) in patients with advanced gastric or gastroesophageal junction (GEJ) cancer that has progressed after first-line chemotherapy (KEYNOTE-061)

被引：0
|
作者：
Van Cutsem, E. [1 ,2 ]
Amonkar, M. [3 ]
Fuchs, C. S. [4 ]
Alsina, M. [5 ,6 ]
Ozguroglu, M. [7 ]
Bang, Y-J. [8 ]
Chung, H. C. [9 ]
Muro, K. [10 ]
Goekkurt, E. [11 ]
Benson, A. [12 ]
Sun, W. [13 ]
Wainberg, Z. A. [14 ]
Norquist, J. [3 ]
Chen, X. [3 ]
Shih, C-S. [3 ]
Shitara, K. [15 ]
机构：
[1] Univ Hosp Gasthuisberg Leuven, Digest Oncol, Leuven, Belgium
[2] Katholieke Univ Leuven, Leuven, Belgium
[3] Merck & Co Inc, Med Oncol, Kenilworth, NJ USA
[4] Yale Canc Ctr, Med Oncol, New Haven, CT USA
[5] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
[6] Univ Autonoma Barcelona, Inst Oncol VHIO, Barcelona, Spain
[7] Istanbul Univ Cerrahpasa, Clin Trial Unit, Cerrahpasa Sch Med, Internal Med,Med Oncol, Istanbul, Turkey
[8] Seoul Natl Univ, Internal Med, Coll Med, Seoul, South Korea
[9] Yonsei Univ, Med Oncol, Coll Med, Yonsei Canc Ctr, Seoul, South Korea
[10] Aichi Canc Ctr Hosp, Clin Oncol, Nagoya, Aichi, Japan
[11] Univ Canc Ctr Hamburg, HOPE, North German Trial Ctr Innovat Oncol NIO, Hamburg, Germany
[12] Northwestern Med Fac Fdn, Hematol Oncol, Chicago, IL USA
[13] Univ Kansas, Internal Med, Med Oncol, Westwood, KS USA
[14] Univ Calif Los Angeles, David Geffen Sch Med, Med Hematol & Oncol, Los Angeles, CA 90095 USA
[15] Natl Canc Ctr Hosp, Gastrointestinal Oncol, Chiba, Japan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
791P
引用
收藏
页码：304 / 304
页数：1
相关论文
共 50 条
  • [21] Pembrolizumab versus paclitaxel for previously treated patients with PD-L1-positive advanced gastric or gastroesophageal junction cancer (GC): Update from the phase III KEYNOTE-061 trial.
    Fuchs, Charles S.
    Ozguroglu, Mustafa
    Bang, Yung-Jue
    Di Bartolomeo, Maria
    Mandala, Mario
    Ryu, Min-hee
    Fornaro, Lorenzo
    Olesinski, Tomasz
    Caglevic, Christian
    Chung, Hyun Cheol
    Muro, Kei
    Van Cutsem, Eric
    Elme, Anneli
    Thuss-Patience, Peter C.
    Chau, Ian
    Ohtsu, Atsushi
    Bhagia, Pooja
    Wang, Anran
    Shih, Chie-Schin
    Shitara, Kohei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
    Fuchs, Charles S.
    Ozguroglu, Mustafa
    Bang, Yung-Jue
    Di Bartolomeo, Maria
    Mandala, Mario
    Ryu, Min-Hee
    Fornaro, Lorenzo
    Olesinski, Tomasz
    Caglevic, Christian
    Chung, Hyun C.
    Muro, Kei
    Van Cutsem, Eric
    Elme, Anneli
    Thuss-Patience, Peter
    Chau, Ian
    Ohtsu, Atsushi
    Bhagia, Pooja
    Wang, Anran
    Shih, Chie-Schin
    Shitara, Kohei
    GASTRIC CANCER, 2022, 25 (01) : 197 - 206
  • [23] KEYNOTE-062: Phase III study of pembrolizumab (MK-3475) alone or in combination with chemotherapy versus chemotherapy alone as first-line therapy for advanced gastric or gastroesophageal junction (GEJ) adenocarcinoma.
    Tabernero, Josep
    Bang, Yung-Jue
    Fuchs, Charles S.
    Ohtsu, Atsushi
    Kher, Uma
    Lam, Baohoang
    Koshiji, Minori
    Van Cutsem, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [24] HEALTH-RELATED QUALITY OF LIFE (HRQoL) OF PEMBROLIZUMAB VS CHEMOTHERAPY FOR PREVIOUSLY TREATED ADVANCED UROTHELIAL CANCER (UC) IN KEYNOTE-045
    Quinn, David
    Vaughn, David J.
    Bellmunt, Joaquim
    de Wit, Ronald
    Fradet, Yves
    Lee, Jae Lyun
    Fong, Lawrence
    Vogelzang, Nicholas J.
    Climent, Miguel A.
    Petrylak, Daniel P.
    Choueiri, Toni K.
    Necchi, Andrea
    Gerritsen, Winald
    Gurney, Howard
    Culine, Stephane
    Sternberg, Cora N.
    Mai, Yabing
    Li, Haojie
    Perini, Rodolfo
    Bajorin, Dean F.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 56 - 56
  • [25] Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy
    Kim, Hye Ryun
    Kim, Jee Hung
    Rhee, Yumie
    Lee, Hosun
    Song, Seung Eun
    Kim, Chan
    Song, Sukyung
    Noh, Sung Hoon
    Rha, Sun Young
    ONCOLOGY, 2016, 90 (05) : 248 - 254
  • [26] Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial
    Charles S. Fuchs
    Mustafa Özgüroğlu
    Yung-Jue Bang
    Maria Di Bartolomeo
    Mario Mandala
    Min-Hee Ryu
    Lorenzo Fornaro
    Tomasz Olesinski
    Christian Caglevic
    Hyun C. Chung
    Kei Muro
    Eric Van Cutsem
    Anneli Elme
    Peter Thuss-Patience
    Ian Chau
    Atsushi Ohtsu
    Pooja Bhagia
    Anran Wang
    Chie-Schin Shih
    Kohei Shitara
    Gastric Cancer, 2022, 25 : 197 - 206
  • [27] Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
    Moehler, Markus
    Xiao, Hong
    Blum, Steven I.
    Elimova, Elena
    Cella, David
    Shitara, Kohei
    Ajani, Jaffer A.
    Janjigian, Yelena Y.
    Garrido, Marcelo
    Shen, Lin
    Yamaguchi, Kensei
    Liu, Tianshu
    Schenker, Michael
    Kowalyszyn, Ruben
    Bragagnoli, Arinilda Campos
    Bruges, Ricardo
    Montesarchio, Vincenzo
    Pazo-Cid, Roberto
    Hunter, Shannon
    Davenport, Eric
    Wang, Jinyi
    Kondo, Kaoru
    Li, Mingshun
    Wyrwicz, Lucjan
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (35) : 5388 - +
  • [28] Health-related quality of life (HRQoL) impact of pembrolizumab (pembro) versus best supportive care (BSC) in previously systemically treated patients (pts) with advanced hepatocellular carcinoma (HCC): KEYNOTE-240
    Merle, P.
    Kulkarni, A. S.
    Ryoo, B-Y.
    Cheng, A-L.
    Kudo, M.
    Bouattour, M.
    Lim, H. Y.
    Breder, V.
    Edeline, J.
    Chao, Y.
    Ogasawara, S.
    Yau, T.
    Garrido, M.
    Chan, S.
    Daniele, B.
    Norquist, J.
    Chen, E.
    Siegel, A. B.
    Zhu, A. X.
    Finn, R. S.
    ANNALS OF ONCOLOGY, 2019, 30 : 256 - 256
  • [29] Self-reported health-related quality of life predicts survival for patients with advanced gastric cancer treated with first-line chemotherapy
    Park, Se Hoon
    Cho, Moon Sook
    Kim, Young Saing
    Hong, Junshik
    Nam, Eunmi
    Park, Jinny
    Cho, Eun Kyung
    Shin, Dong Bok
    Lee, Jae Hoon
    Lee, Woon Kee
    QUALITY OF LIFE RESEARCH, 2008, 17 (02) : 207 - 214
  • [30] Assessment of adrenal function and health-related quality of life in patients with advanced gastric cancer who received first-line chemotherapy.
    Lee, H.
    Kim, H. R.
    Song, S.
    Kim, C.
    Lee, S. S.
    Song, S. K.
    Lim, S.
    Kim, G. M.
    Noh, S. H.
    Rha, S. Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345